Biblio
Export 71 results:
[ Author
Filters: First Letter Of Last Name is J [Clear All Filters]
“A Review of the Familial Alzheimer's Disease Locus PRESENILIN 2 and Its Relationship to PRESENILIN 1.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1323-1339, 2018.
, “Dynamics of the Complement, Cytokine, and Chemokine Systems in the Regulation of Synaptic Function and Dysfunction Relevant to Alzheimer's Disease.”, J Alzheimers Dis, vol. 57, no. 4, pp. 1123-1135, 2017.
, “Evaluation of the Reliability, Validity, and Predictive Validity of the Subscales of the Perceived Stress Scale in Older Adults.”, J Alzheimers Dis, vol. 59, no. 3, pp. 987-996, 2017.
, “Role of the Glyoxalase System in Alzheimer's Disease.”, J Alzheimers Dis, vol. 66, no. 3, pp. 887-899, 2018.
, “The Gut Microbiota and Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 1, pp. 1-15, 2017.
, “Memory-Related Frontal Brainwaves Predict Transition to Mild Cognitive Impairment in Healthy Older Individuals Five Years Before Diagnosis.”, J Alzheimers Dis, vol. 79, no. 2, pp. 531-541, 2021.
, “Association of Plasma Amyloid-β and Dementia Among Black and White Older Adults.”, J Alzheimers Dis, vol. 99, no. 2, pp. 787-797, 2024.
, “Efficacy and Safety of Donepezil in Chinese Patients with Severe Alzheimer's Disease: A Randomized Controlled Trial.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1495-1504, 2017.
, “A 19-Year-Old Adolescent with Probable Alzheimer's Disease.”, J Alzheimers Dis, vol. 91, no. 3, pp. 915-922, 2023.
, “Stress-Induced Synaptic Dysfunction and Neurotransmitter Release in Alzheimer's Disease: Can Neurotransmitters and Neuromodulators be Potential Therapeutic Targets?”, J Alzheimers Dis, vol. 57, no. 4, pp. 1017-1039, 2017.
, “Hypoxia-Induced Signaling Activation in Neurodegenerative Diseases: Targets for New Therapeutic Strategies.”, J Alzheimers Dis, vol. 62, no. 1, pp. 15-38, 2018.
, “Progression from Subjective Cognitive Decline to Mild Cognitive Impairment or Dementia: The Role of Baseline Cognitive Performance.”, J Alzheimers Dis, vol. 86, no. 4, pp. 1763-1774, 2022.
, “Altered Expression of Urea Cycle Enzymes in Amyloid-β Protein Precursor Overexpressing PC12 Cells and in Sporadic Alzheimer's Disease Brain.”, J Alzheimers Dis, vol. 62, no. 1, pp. 279-291, 2018.
, “Cognitive Function Associated with Gut Microbial Abundance in Sucrose and S-Adenosyl-L-Methionine (SAMe) Metabolic Pathways.”, J Alzheimers Dis, vol. 87, no. 3, pp. 1115-1130, 2022.
, “Administering Cognitive Tests Through Touch Screen Tablet Devices: Potential Issues.”, J Alzheimers Dis, vol. 54, no. 3, pp. 1169-1182, 2016.
, “Multiple System Atrophy: An Oligodendroglioneural Synucleinopathy1.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1141-1179, 2018.
, “Development of a Proxy-Free Objective Assessment Tool of Instrumental Activities of Daily Living in Mild Cognitive Impairment Using Smart Home Technologies.”, J Alzheimers Dis, vol. 52, no. 2, pp. 509-17, 2016.
, “The Effect of Exercise on Falls in People Living with Dementia: A Systematic Review.”, J Alzheimers Dis, vol. 92, no. 4, pp. 1199-1217, 2023.
, “The Vanderbilt Memory & Aging Project: Study Design and Baseline Cohort Overview.”, J Alzheimers Dis, vol. 52, no. 2, pp. 539-59, 2016.
, “Evidence For and Against a Pathogenic Role of Reduced γ-Secretase Activity in Familial Alzheimer's Disease.”, J Alzheimers Dis, vol. 52, no. 3, pp. 781-99, 2016.
, “Pazopanib Reduces Phosphorylated Tau Levels and Alters Astrocytes in a Mouse Model of Tauopathy.”, J Alzheimers Dis, vol. 60, no. 2, pp. 461-481, 2017.
, “Atherosclerosis, Hypertension, and Diabetes in Alzheimer's Disease, Vascular Dementia, and Mixed Dementia: Prevalence and Presentation.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1247-1258, 2018.
, “Dementia and Pressure Ulcers: Is There a Close Pathophysiological Interrelation?”, J Alzheimers Dis, vol. 56, no. 3, pp. 861-866, 2017.
, “Hospitalization after Oral Antibiotic Initiation in Finnish Community Dwellers with and without Alzheimer's Disease: Retrospective Register-Based Cohort Study.”, J Alzheimers Dis, vol. 64, no. 2, pp. 437-445, 2018.
, “Medial Temporal Lobe Atrophy in Predementia Alzheimer's Disease: A Longitudinal Multi-Site Study Comparing Staging and A/T/N in a Clinical Research Cohort.”, J Alzheimers Dis, vol. 94, no. 1, pp. 259-279, 2023.
,